I've attached a presentation done by Athersys in August 2020.
Reason for posting this is because they completed a Phase 2 ARDS trial in 2018/19, and had 12 month follow up on patients Announced in Jan 2020. It does provide some interesting reading.
Pages from 08-10-20-ATHX-Investor-Presentation-August.pdf
Cell Therapy News/Articles, page-6042
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |